Early prediction of the response of breast tumors to neoadjuvant chemotherapy using quantitative MRI and machine learning.

The ability to predict early in the course of treatment the response of breast tumors to neoadjuvant chemotherapy can stratify patients based on response for patient-specific treatment strategies. Currently response to neoadjuvant chemotherapy is evaluated based on physical exam or breast imaging (mammogram, ultrasound or conventional breast MRI). There is a poor correlation among these measurements and with the actual tumor size when measured by the pathologist during definitive surgery. We tested the feasibility of using quantitative MRI as a tool for early prediction of tumor response. Between 2007 and 2010 twenty consecutive patients diagnosed with Stage II/III breast cancer and receiving neoadjuvant chemotherapy were enrolled on a prospective imaging study. Our study showed that quantitative MRI parameters along with routine clinical measures can predict responders from non-responders to neoadjuvant chemotherapy. The best predictive model had an accuracy of 0.9, a positive predictive value of 0.91 and an AUC of 0.96.

[1]  Constantin F. Aliferis,et al.  Local Causal and Markov Blanket Induction for Causal Discovery and Feature Selection for Classification Part I: Algorithms and Empirical Evaluation , 2010, J. Mach. Learn. Res..

[2]  Baljit Singh,et al.  A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer. , 2003, Clinical Cancer Research.

[3]  C. V. D. van de Velde,et al.  Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Derek H. Sleeman,et al.  Analysing PET scans data for predicting response to chemotherapy in breast cancer patients , 2007, SGAI Conf..

[5]  Andreas Makris,et al.  Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer , 2008, Clinical Cancer Research.

[6]  D. Wickerham,et al.  Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Robert M. Nishikawa,et al.  A study on several Machine-learning methods for classification of Malignant and benign clustered microcalcifications , 2005, IEEE Transactions on Medical Imaging.

[8]  A. Padhani,et al.  Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging , 2002, NMR in biomedicine.

[9]  S. Singletary,et al.  Accuracy of Physical Examination, Ultrasonography, and Mammography in Predicting Residual Pathologic Tumor Size in Patients Treated With Neoadjuvant Chemotherapy , 2006, Annals of surgery.

[10]  Wei-Yin Loh,et al.  Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..

[11]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[12]  Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast Cancers , 2005 .

[13]  José Antonio Gómez-Ruiz,et al.  A combined neural network and decision trees model for prognosis of breast cancer relapse , 2003, Artif. Intell. Medicine.

[14]  Gregory F. Cooper,et al.  Causal Discovery Using A Bayesian Local Causal Discovery Algorithm , 2004, MedInfo.

[15]  Elkan F Halpern,et al.  Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. , 2003, Radiology.

[16]  G. Hortobagyi,et al.  Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Martin O. Leach,et al.  The UK MARIBS Breast Screening Study: Evaluation of radiological features for breast tumour classification in clinical screening with machine learning methods , 2005, Artif. Intell. Medicine.

[18]  Edward H. Shortliffe,et al.  The Computer Meets Medicine and Biology: Emergence of a Discipline , 2001 .

[19]  J. Bryant,et al.  Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. , 2001, Journal of the National Cancer Institute. Monographs.

[20]  R. Gillies,et al.  Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. , 1999, Neoplasia.

[21]  Vladimir Vapnik,et al.  Statistical learning theory , 1998 .

[22]  Isabelle Guyon,et al.  An Introduction to Variable and Feature Selection , 2003, J. Mach. Learn. Res..

[23]  G. Arfken.  Mathematical Methods for Physicists , 1967 .

[24]  Chih-Jen Lin,et al.  LIBLINEAR: A Library for Large Linear Classification , 2008, J. Mach. Learn. Res..

[25]  Bradford A Moffat,et al.  Prospective Early Response Imaging Biomarker for Neoadjuvant Breast Cancer Chemotherapy , 2007, Clinical Cancer Research.

[26]  William W. Cohen.  Fast Effective Rule Induction , 1995, ICML.

[27]  S. Paik,et al.  Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Dursun Delen,et al.  Predicting breast cancer survivability: a comparison of three data mining methods , 2005, Artif. Intell. Medicine.

[29]  J. Bryant,et al.  Pathobiology of preoperative chemotherapy , 2002 .

[30]  Thomas E Yankeelov,et al.  The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer. , 2011, Seminars in oncology.

[31]  Risto A Kauppinen,et al.  Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy , 2002, NMR in biomedicine.

[32]  Anna L. Brown,et al.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  William E Gillanders,et al.  Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. , 2010, American journal of surgery.